Kane Biotech Schedules Fourth Quarter and Full Year 2017 Earnings Conference Call and Business Update
Conference call to take place Thursday, March 22, 2018 at 4:30pm E.T.
WINNIPEG, Manitoba – (Globe Newswire – March 16, 2018) – Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will host a conference call on Thursday, March 22, 2018 at 4:30pm E.T. to discuss its financial results for the fourth quarter and full year 2017, in conjunction with the filing of its annual Year End Financial Statements for the fourth quarter and full year ended December 31, 2017.
Mark Ahrens-Townsend, President and Chief Executive Officer, and Ray Dupuis, Chief Financial Officer of Kane, will host the call and provide an update on recent developments and clinical progress. Management will be answering questions live immediately following the earnings announcement part of the call.
To participate in the call, please dial +1 877-268-9044 (toll-free) in the U.S. and Canada. The conference ID number is 2680589.
Event: FY+ 2017 Earnings and Business Update Conference Call
Date: Thursday, March 22, 2018
Time: 4:30pm E.T.
U.S. & Canada Dial-in: 877-268-9044 (toll free)
Conference ID: 2680589
Webcast Link: https://edge.media-server.com/m6/p/pvvmdwpp
A live audio webcast of the conference call will also be available on the investor relations page of Kane’s corporate website at www.kanebiotech.com In addition, the recorded conference call can be replayed and will be available for 90 days following the call on Kane’s website.